Areas of Interest
Our Areas of Interest
The following areas reflect the company's current research, dialogue and project development interests. They do not represent products manufactured, licensed, distributed or marketed by İKRA Biotechnologies.
Area of Interest
Plasma Fractionation
We are exploring the strategic, technological and commercial dimensions of plasma fractionation projects that may be developed in international markets.
Our current interest includes:
- regional demand for plasma-derived medicinal products,
- plasma collection and qualified plasma supply requirements,
- possible facility capacity models,
- technology licensing and know-how transfer structures,
- potential product prioritisation,
- yield and recovery expectations,
- project financing models,
- regulatory pathways,
- and possible international partnerships.
Area of Interest
Plasma-Derived Medicinal Products
We are reviewing the broader international landscape surrounding plasma-derived medicinal products and their relevance to regional healthcare systems.
Product areas being examined from a strategic perspective may include:
- immunoglobulins,
- human albumin,
- selected coagulation proteins,
- hyperimmune immunoglobulins,
- and other selected plasma-derived therapies.
Area of Interest
Biologics Technologies
Our interests extend to technologies and project models related to advanced biologics.
This may include the evaluation of:
- biologics manufacturing technologies,
- upstream and downstream processing systems,
- purification technologies,
- analytical and quality-control capabilities,
- process development,
- quality infrastructure,
- technology transfer models,
- workforce development,
- and future regional manufacturing opportunities.
Area of Interest
Technology Licensing Opportunities
We are interested in engaging with technology owners and specialist organisations that may be open to discussing licensing, know-how transfer, technical assistance or collaborative project development.
Any prospective licensing opportunity would require assessment of:
- intellectual property ownership,
- freedom to operate,
- patent and territorial limitations,
- existing regulatory history,
- commercial references,
- demonstrated process performance,
- transfer scope,
- technical support,
- training requirements,
- financial terms,
- and territorial and commercial rights.
Area of Interest
International Investment Models
We explore how biotechnology projects may be financed, governed and structured across different countries and markets.
Our areas of interest may include:
- strategic equity participation,
- joint ventures,
- project finance,
- public funding mechanisms,
- development finance,
- technology-for-equity structures,
- regional investment partnerships,
- and phased investment models.
Area of Interest
Regional Manufacturing Projects
We are interested in the potential development of biotechnology manufacturing projects outside Türkiye, particularly where regional demand, investment support, technology access and healthcare priorities may create a viable and sustainable opportunity.
The selection of any future project location would depend on:
- local legal and regulatory requirements,
- infrastructure availability,
- investment incentives,
- market access,
- workforce availability,
- qualified plasma or raw-material supply,
- supply-chain security,
- project financing,
- technology availability,
- and formal agreements with local stakeholders.
Area of Interest
Strategic and Academic Collaborations
We welcome dialogue with universities, scientific institutions, technology centres and subject-matter experts.
Potential areas of academic and strategic interaction may include:
- scientific advisory support,
- feasibility studies,
- technology assessment,
- analytical development,
- workforce education and training,
- regulatory research,
- market analysis,
- process-development studies,
- and collaborative knowledge development.
Let Us Explore Whether There Is a Project Worth Developing
We welcome introductory discussions with technology providers, investors, engineering organisations, consultants, academic institutions, financial organisations and potential regional partners.
Our objective is to understand relevant capabilities, identify areas of mutual interest and determine whether a potential opportunity merits further technical, commercial, financial or regulatory evaluation.
An initial discussion does not create an agency relationship, exclusivity arrangement, partnership, joint venture, investment commitment, licence, representation authority or other binding obligation.
Corporate Status Notice
İKRA Biotechnologies is an independent biotechnology project development venture focused on international technology, investment, licensing and partnership opportunities.
The company does not currently:
- operate a biotechnology or pharmaceutical manufacturing facility,
- manufacture plasma-derived medicinal products or other biologics,
- own or license a commercial plasma fractionation technology,
- hold a medicinal product manufacturing authorisation,
- hold a marketing authorisation for any medicinal product,
- or act as an authorised distributor of medicinal products.
The areas described on this website represent the company's current interests, research activities, stakeholder discussions and potential project development objectives.
All future projects would remain subject to feasibility assessment, financing, scientific and technical evaluation, due diligence, contractual agreement and approval by the relevant authorities.